dosage increase for tirzepatide (Mounjaro) the Treatment of Type 2 Diabetes Mellitus Personalizing Your Tirzepatide Dose: A

In Study 8, at Week 72, the body weight was missing for 5.5%, 6.0% and 15.0% of patients randomized to WEGOVY 7.2 mg, WEGOVY 2.4 mg and placebo, respectively

Most people have never heard of MTHFR until a test result stops them in their tracks

And to show we're not making this stuff up: The mechanisms underlying these effects involve multiple cellular targets to elevate brain-derived neurotropic factor (BDNF) levels, reduce microglia activation, and decrease levels of proinflammatory mediators So...we have both the growth side (BDNF and neurogenesis) and protection from the insulting side (microglia hyperactivation and inflammation)

Available as injectable or intranasal

Mounjaro is typically administered as a once-weekly subcutaneous injection to support weight loss

doi:10.1186/s12937-021-00739-9 9